Premium
Wuxi Biologics Cayman Inc (PK) (WXIBF)
USOTC
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-03-27 | Dr. Xuejun GuCTO, Exec. VP of Global Biologics Development Department & Executive Director | 148,13k | 0,00 | Derivative Exercise and Retained Stock | - | 1,32M | 12,63% |
| 2026-03-27 | Dr. Zhisheng ChenCEO & Executive Director | 16,72k | 0,00 | Derivative Exercise and Retained Stock | - | 46,04M | 0,04% |
| 2025-11-14 | Dr. Zhisheng ChenCEO & Executive Director | 3,00M | 499,24k | Derivative Exercise and Retained Stock | 0,17 | 38,97M | 8,34% |
| 2026-02-19 | BlackRock, Inc.Société | -18,21M | 0,00 | Other Disposition | - | 70,00M | -20,64% |
| 2026-02-11 | BlackRock, Inc.Société | -19,13M | 0,00 | Other Disposition | - | 69,99M | -21,46% |
| 2026-01-20 | Wuxi Biologics Holdings LimitedSociété | -150,00M | 740,92M | Vente | 4,94 | 351,25M | -29,93% |
| 2026-01-05 | BlackRock, Inc.Société | -21,77M | 0,00 | Other Disposition | - | 65,78M | -24,86% |
| 2025-12-30 | Dr. Zhisheng ChenCEO & Executive Director | -18,90M | 0,00 | Other Disposition | - | 45,89M | -29,17% |
| 2025-12-17 | Dr. Zhisheng ChenCEO & Executive Director | -8,80M | 0,00 | Other Disposition | - | 45,89M | -16,09% |
| 2025-12-02 | Dr. Zhisheng ChenCEO & Executive Director | -3,16M | 12,68M | Vente | 4,01 | 45,89M | -6,44% |
| 2025-12-02 | Dr. Xuejun GuCTO, Exec. VP of Global Biologics Development Department & Executive Director | -41,64k | 168,26k | Vente | 4,04 | 1,30M | -3,11% |
| 2025-11-28 | BlackRock, Inc.Société | -6,83M | 0,00 | Other Disposition | - | 65,31M | -9,46% |
| 2025-11-27 | Dr. Zhisheng ChenCEO & Executive Director | -3,13M | 12,80M | Vente | 4,09 | 40,56M | -7,16% |
| 2025-11-28 | Dr. Zhisheng ChenCEO & Executive Director | 10,06M | 1,67M | Derivative Exercise and Retained Stock | 0,17 | 49,05M | 25,80% |
| 2025-11-28 | Dr. Zhisheng ChenCEO & Executive Director | -1,56M | 6,42M | Vente | 4,11 | 49,05M | -3,09% |
| 2025-11-25 | Dr. Zhisheng ChenCEO & Executive Director | 6,00M | 997,70k | Derivative Exercise and Retained Stock | 0,17 | 40,68M | 17,30% |
| 2025-11-26 | Dr. Zhisheng ChenCEO & Executive Director | 3,00M | 498,84k | Derivative Exercise and Retained Stock | 0,17 | 43,68M | 7,37% |
| 2025-11-21 | Dr. Xuejun GuCTO, Exec. VP of Global Biologics Development Department & Executive Director | 46,87k | 0,00 | Derivative Exercise and Retained Stock | - | 1,34M | 3,63% |
| 2025-11-20 | Dr. Zhisheng ChenCEO & Executive Director | -1,56M | 6,40M | Vente | 4,09 | 35,46M | -4,22% |
| 2025-11-21 | Dr. Zhisheng ChenCEO & Executive Director | -781,89k | 3,19M | Vente | 4,08 | 34,68M | -2,20% |
| 2025-11-19 | Dr. Zhisheng ChenCEO & Executive Director | 1,50M | 249,10k | Derivative Exercise and Retained Stock | 0,17 | 37,03M | 4,22% |
| 2025-11-18 | Dr. Zhisheng ChenCEO & Executive Director | 3,00M | 498,47k | Derivative Exercise and Retained Stock | 0,17 | 35,53M | 9,22% |
| 2025-11-18 | Dr. Zhisheng ChenCEO & Executive Director | -1,56M | 6,80M | Vente | 4,36 | 35,53M | -4,20% |
| 2025-11-17 | Dr. Zhisheng ChenCEO & Executive Director | -4,88M | 21,57M | Vente | 4,36 - 4,43 | 34,09M | -12,52% |
| 2025-11-13 | Dr. Zhisheng ChenCEO & Executive Director | 8,50M | 1,41M | Derivative Exercise and Retained Stock | 0,17 | 31,37M | 37,17% |
| 2025-11-13 | Dr. Zhisheng ChenCEO & Executive Director | -2,34M | 10,00M | Vente | 4,27 | 31,37M | -6,94% |
| 2025-11-14 | Dr. Zhisheng ChenCEO & Executive Director | -3,90M | 16,72M | Vente | 4,29 | 35,97M | -9,78% |
| 2025-11-12 | Dr. Zhisheng ChenCEO & Executive Director | 5,89M | 980,97k | Derivative Exercise and Retained Stock | 0,17 | 33,71M | 21,19% |
| 2025-11-12 | Dr. Zhisheng ChenCEO & Executive Director | -2,08M | 8,88M | Derivative Exercise and Sale | 0,17 - 4,40 | 33,71M | - |
| 2025-11-12 | Dr. Xuejun GuCTO, Exec. VP of Global Biologics Development Department & Executive Director | 2,58k | 0,00 | Derivative Exercise and Retained Stock | - | 1,29M | 0,20% |
| 2025-11-11 | Dr. Zhisheng ChenCEO & Executive Director | 2,68M | 446,25k | Derivative Exercise and Retained Stock | 0,17 | 27,81M | 10,67% |
| 2025-11-11 | Dr. Zhisheng ChenCEO & Executive Director | -1,82M | 7,62M | Derivative Exercise and Sale | 0,17 - 4,36 | 27,81M | - |
| 2025-11-10 | Dr. Zhisheng ChenCEO & Executive Director | 885,24k | 147,28k | Derivative Exercise and Retained Stock | 0,17 | 25,13M | 3,65% |
| 2025-11-10 | Dr. Zhisheng ChenCEO & Executive Director | -3,11M | 13,35M | Derivative Exercise and Sale | 0,17 - 4,45 | 25,13M | - |
| 2025-11-06 | Dr. Zhisheng ChenCEO & Executive Director | 9,50M | 1,58M | Derivative Exercise and Retained Stock | 0,17 | 24,25M | 64,42% |
| 2025-11-03 | Dr. Zhisheng ChenCEO & Executive Director | -996,00k | 0,00 | Other Disposition | - | 14,75M | -6,33% |
| 2025-10-09 | BlackRock, Inc.Société | -10,40M | 0,00 | Other Disposition | - | 64,13M | -13,96% |
| 2025-10-07 | BlackRock, Inc.Société | -36,77M | 0,00 | Other Disposition | - | 64,13M | -36,44% |
| 2025-10-01 | BlackRock, Inc.Société | -8,48M | 0,00 | Other Disposition | - | 64,13M | -11,68% |
| 2025-09-08 | Dr. Zhisheng ChenCEO & Executive Director | 6,00M | 995,80k | Derivative Exercise and Retained Stock | 0,17 | 29,75M | 25,27% |
| 2025-09-10 | Dr. Zhisheng ChenCEO & Executive Director | -6,00M | 29,42M | Vente | 4,90 | 14,75M | -28,92% |
| 2025-09-05 | Dr. Zhisheng ChenCEO & Executive Director | 9,00M | 1,49M | Derivative Exercise and Retained Stock | 0,17 | 23,75M | 61,03% |
| 2025-09-09 | Dr. Zhisheng ChenCEO & Executive Director | -9,00M | 42,48M | Vente | 4,72 | 20,75M | -30,25% |
| 2025-08-21 | BlackRock, Inc.Société | -4,32M | 0,00 | Other Disposition | - | 64,09M | -6,32% |
| 2025-08-14 | BlackRock, Inc.Société | -14,54M | 0,00 | Other Disposition | - | 72,48M | -16,71% |
| 2025-07-11 | BlackRock, Inc.Société | -6,67M | 0,00 | Other Disposition | - | 62,77M | -9,61% |
| 2025-07-09 | BlackRock, Inc.Société | -6,41M | 0,00 | Other Disposition | - | 62,77M | -9,27% |
| 2025-07-04 | BlackRock, Inc.Société | -14,22M | 0,00 | Other Disposition | - | 62,36M | -18,57% |
| 2025-06-24 | BlackRock, Inc.Société | -9,23M | 0,00 | Other Disposition | - | 61,30M | -13,09% |
| 2025-06-18 | Wuxi Biologics Holdings LimitedSociété | -82,94M | 281,05M | Vente | 3,39 | 501,25M | -14,20% |
| 2025-06-17 | BlackRock, Inc.Société | -22,76M | 0,00 | Other Disposition | - | 61,41M | -27,04% |
| 2025-06-16 | Dr. Zhisheng ChenCEO & Executive Director | 189,04k | 0,00 | Derivative Exercise and Retained Stock | - | 14,64M | 1,31% |
| 2025-06-10 | Dr. Zhisheng ChenCEO & Executive Director | 264,87k | 0,00 | Derivative Exercise and Retained Stock | - | 14,45M | 1,87% |
| 2025-06-10 | Dr. Xuejun GuCTO, Exec. VP of Global Biologics Development Department & Executive Director | 29,68k | 0,00 | Derivative Exercise and Retained Stock | - | 1,28M | 2,38% |
| 2025-06-06 | BlackRock, Inc.Société | -6,18M | 0,00 | Other Disposition | - | 60,84M | -9,21% |
| 2025-06-04 | BlackRock, Inc.Société | -4,32M | 0,00 | Other Disposition | - | 60,84M | -6,63% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
